Evidence map›Paper›PMID 36947445›Full record

ArticleMicrobial genomics2023

Rapid adaptations of

Daniël Leenheer, Anaísa B Moreno, Kiran Paranjape, Susan Murray, Sophie Jarraud, Christophe Ginevra, Lionel Guy

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Current research in microbial sciences · 2025
    Article
  4. Omadacycline successfully treated severeFrontiers in pharmacology · 2025
    Article
  5. Article
  6. Severe Legionnaires' disease.Annals of intensive care · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Daniël LeenheerDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Anaísa B MorenoDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Kiran ParanjapeDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Susan MurrayDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Sophie JarraudFrench National Reference Center of Legionella, Institute of Infectious Agents, Hospices Civils de Lyon, Lyon, France.
Christophe GinevraFrench National Reference Center of Legionella, Institute of Infectious Agents, Hospices Civils de Lyon, Lyon, France.
Lionel GuyDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Uppsala University · SEUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LegionellaLegionella pneumophilaLegionnaires' DiseaseHumansMacrophagescomparative genomicshost-specific adaptationsLegionella pneumophilaLegionnaires’ diseasemolecular evolution

Identifiers

PMID36947445
PMCPMC10132064
OpenAlexW4353020380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.